Myomo logo

Myomo share price today

(MYO)

Myomo share price is $6.83 & ₹586.08 as on 7 Jan 2025, 2.30 'hrs' IST

$6.83

0.24

(3.64%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Myomo share price in Dollar and Rupees. Guide to invest in Myomo stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Myomo, along with analyst recommendations, forecasts, and comprehensive financials.

Myomo share price movements

  • Today's Low: $6.42
    Today's High: $6.94

    Day's Volatility :7.48%

  • 52 Weeks Low: $2.51
    52 Weeks High: $6.83

    52 Weeks Volatility :63.24%

Myomo Returns

PeriodMyomo IncIndex (Russel 2000)
3 Months
67.68%
0.0%
6 Months
41.72%
0.0%
1 Year
32.6%
0.0%
3 Years
-15.94%
-19.8%

Myomo Key Statistics

in dollars & INR

Previous Close
$6.59
Open
$6.87
Today's High
$6.94
Today's Low
$6.421
Market Capitalization
$217.0M
Today's Volume
$234.3K
52 Week High
$6.94
52 Week Low
$2.5108
Revenue TTM
$25.2M
EBITDA
$-8.3M
Earnings Per Share (EPS)
$-0.23
Profit Margin
-33.22%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-82.54%

How to invest in Myomo from India?

It is very easy for Indian residents to invest directly in Myomo from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Myomo stock in both Indian Rupees (INR) and US Dollars (USD). Search for Myomo or MYO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Myomo or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Myomo shares which would translate to 0.126 fractional shares of Myomo as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Myomo, in just a few clicks!

Returns in Myomo for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Myomo investment value today

Current value as on today

₹1,40,647

Returns

₹40,647

(+40.65%)

Returns from Myomo Stock

₹37,425 (+37.42%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Myomo

-44%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Myomo on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -44% less investors are searching Myomo in the last 30 days versus the previous period.

Analyst Recommendation on Myomo

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Myomo(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Myomo

What analysts predicted

Upside of 12.25%

Current:

$6.83

Target:

$7.67

Insights on Myomo

  • Price Movement

    In the last 3 months, MYO stock has moved up by 63.9%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 3.75M → 9.20M (in $), with an average increase of 34.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -3.83M → -966.40K (in $), with an average increase of 129.0% per quarter
  • MYO vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 16.9%
  • MYO vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 118.2%
  • Price to Sales

    ForMYO every $1 of sales, investors are willing to pay $7.9, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Myomo Financials in INR & Dollars

FY18Y/Y Change
Revenue
$2.4M
↑ 56.79%
Net Income
$-10.3M
↓ 14.72%
Net Profit Margin
-422.11%
↑ 353.93%
FY19Y/Y Change
Revenue
$3.8M
↑ 57.02%
Net Income
$-10.6M
↑ 3.05%
Net Profit Margin
-277.01%
↑ 145.1%
FY20Y/Y Change
Revenue
$7.6M
↑ 97.6%
Net Income
$-12.0M
↑ 13.24%
Net Profit Margin
-158.75%
↑ 118.26%
FY21Y/Y Change
Revenue
$13.9M
↑ 82.72%
Net Income
$-10.4M
↓ 13.84%
Net Profit Margin
-74.86%
↑ 83.89%
FY22Y/Y Change
Revenue
$15.6M
↑ 12.26%
Net Income
$-10.7M
↑ 3.36%
Net Profit Margin
-68.92%
↑ 5.94%
FY23Y/Y Change
Revenue
$19.2M
↑ 23.7%
Net Income
$-8.1M
↓ 24.0%
Net Profit Margin
-42.34%
↑ 26.58%
Q2 FY23Q/Q Change
Revenue
$6.0M
↑ 72.88%
Net Income
$-1.0M
↓ 61.65%
Net Profit Margin
-17.02%
↑ 59.7%
Q3 FY23Q/Q Change
Revenue
$5.1M
↓ 14.75%
Net Income
$-2.0M
↑ 100.07%
Net Profit Margin
-39.95%
↓ 22.93%
Q4 FY23Q/Q Change
Revenue
$4.8M
↓ 6.36%
Net Income
$-2.5M
↑ 21.25%
Net Profit Margin
-51.72%
↓ 11.77%
Q1 FY24Q/Q Change
Revenue
$3.8M
↓ 21.07%
Net Income
$-3.8M
↑ 55.91%
Net Profit Margin
-102.16%
↓ 50.44%
Q2 FY24Q/Q Change
Revenue
$7.5M
↑ 100.32%
Net Income
$-1.1M
↓ 70.76%
Net Profit Margin
-14.91%
↑ 87.25%
Q3 FY24Q/Q Change
Revenue
$9.2M
↑ 22.43%
Net Income
$-966.4K
↓ 13.84%
Net Profit Margin
-10.5%
↑ 4.41%
FY18Y/Y Change
Profit
$1.7M
↑ 62.86%
FY19Y/Y Change
Profit
$2.9M
↑ 70.19%
FY20Y/Y Change
Profit
$5.0M
↑ 70.64%
FY21Y/Y Change
Profit
$10.3M
↑ 106.95%
FY22Y/Y Change
Profit
$10.3M
↓ 0.57%
FY23Y/Y Change
Profit
$13.2M
↑ 28.57%
Q2 FY23Q/Q Change
Profit
$4.3M
↑ 85.52%
Q3 FY23Q/Q Change
Profit
$3.5M
↓ 18.5%
Q4 FY23Q/Q Change
Profit
$3.1M
↓ 11.01%
Q1 FY24Q/Q Change
Profit
$2.3M
↓ 25.95%
Q2 FY24Q/Q Change
Profit
$5.3M
↑ 131.64%
Q3 FY24Q/Q Change
Profit
$6.9M
↑ 30.42%
FY18Y/Y Change
Operating Cash Flow
$-9.6M
↑ 56.11%
Investing Cash Flow
$-126.9K
↑ 89.35%
Financing Cash Flow
$3.3M
↓ 81.84%
FY19Y/Y Change
Operating Cash Flow
$-10.3M
↑ 7.66%
Investing Cash Flow
$-52.0K
↓ 59.02%
Financing Cash Flow
$8.3M
↑ 149.24%
FY20Y/Y Change
Operating Cash Flow
$-9.0M
↓ 12.66%
Investing Cash Flow
$-45.8K
↓ 12.0%
Financing Cash Flow
$16.8M
↑ 101.73%
FY21Y/Y Change
Operating Cash Flow
$-9.5M
↑ 5.7%
Investing Cash Flow
$-326.5K
↑ 613.55%
Financing Cash Flow
$13.2M
↓ 21.53%
FY22Y/Y Change
Operating Cash Flow
$-10.2M
↑ 7.18%
Investing Cash Flow
$-310.8K
↓ 4.8%
Financing Cash Flow
$376.9K
↓ 97.14%
Q2 FY23Q/Q Change
Operating Cash Flow
$-285.5K
↓ 84.28%
Investing Cash Flow
$-3.0M
↑ 6572.63%
Financing Cash Flow
$-8.1K
↓ 100.14%
Q3 FY23Q/Q Change
Operating Cash Flow
$-1.7M
↑ 500.58%
Investing Cash Flow
$-4.3M
↑ 43.72%
Financing Cash Flow
$3.9M
↓ 48578.16%

Myomo Technicals Summary

Sell

Neutral

Buy

Myomo is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Myomo Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Myomo Inc
4.44%
41.72%
32.6%
-15.94%
-34.76%
Stryker Corporation
-5.14%
7.73%
20.51%
37.02%
70.83%
Boston Scientific Corp.
2.22%
18.53%
55.24%
113.84%
98.4%
Edwards Lifesciences Corp.
4.25%
-20.93%
-2.33%
-38.47%
-5.21%
Abbott Laboratories
-0.93%
11.99%
1.27%
-15.84%
31.69%
Medtronic Plc
-3.59%
5.29%
-6.49%
-23.36%
-31.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Myomo Inc
NA
NA
0.0
-0.18
-0.83
-0.31
NA
0.31
Stryker Corporation
38.59
38.59
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.82
73.82
1.62
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.0
28.0
6.67
2.54
0.19
0.11
NA
16.18
Abbott Laboratories
34.38
34.38
2.19
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.43
24.43
1.46
5.45
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Myomo Inc
Buy
$217.0M
-34.76%
NA
-33.22%
Stryker Corporation
Buy
$137.3B
70.83%
38.59
16.34%
Boston Scientific Corp.
Buy
$131.6B
98.4%
73.82
11.26%
Edwards Lifesciences Corp.
Buy
$43.6B
-5.21%
28.0
65.86%
Abbott Laboratories
Buy
$196.2B
31.69%
34.38
13.99%
Medtronic Plc
Buy
$102.4B
-31.62%
24.43
12.06%

About Myomo

myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform functional activities at home, at work, and in the community, resulting in an improved quality of life and lower healthcare costs.
Organization
Myomo
Employees
101
CEO
Mr. Paul R. Gudonis
Industry
Distribution Services

Management People of Myomo

NameTitle
Mr. Paul R. Gudonis
Chairman, President & CEO
Mr. David A. Henry
Chief Financial Officer
Dr. Harry Kovelman M.D.
Chief Medical Officer
Colin Anderson
Global Director of Operations
Mr. Joseph Chicoskie
Director of Marketing
Ms. Galina Shtivelman
Senior Director of Human Resources
Mr. Micah J. Mitchell
Chief Commercial Officer

Important FAQs about investing in Myomo from India :

What is Myomo share price today?

Myomo share price today stands at $6.83, Open: $6.87 ; Previous Close: $6.59 ; High: $6.94 ; Low: $6.42 ; 52 Week High: $6.83 ; 52 Week Low: $2.51. The stock opens at $6.87, after a previous close of $6.59. The stock reached a daily high of $6.94 and a low of $6.42, with a 52-week high of $6.83 and a 52-week low of $2.51.

Can Indians buy Myomo shares?

Yes, Indians can invest in the Myomo (MYO) from India.

With INDmoney, you can buy Myomo at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Myomo at zero transaction cost.

How can I buy Myomo shares from India?

It is very easy to buy Myomo from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Myomo be purchased?

Yes, you can buy fractional shares of Myomo with INDmoney app.

What are the documents required to start investing in Myomo stocks?

To start investing in Myomo, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Myomo

Today’s highest price of Myomo (MYO) is $6.94.

Today’s lowest price of Myomo (MYO) is $6.42.

What is today's market capitalisation of Myomo

Today's market capitalisation of Myomo MYO is 217.0M

What is the 52 Week High and Low Range of Myomo

  • 52 Week High

    $6.83

  • 52 Week Low

    $2.51

What are the historical returns of Myomo?

  • 1 Month Returns

    4.44%

  • 3 Months Returns

    41.72%

  • 1 Year Returns

    32.6%

  • 5 Years Returns

    -34.76%

Who is the Chief Executive Officer (CEO) of Myomo

Mr. Paul R. Gudonis is the current Chief Executive Officer (CEO) of Myomo.